ArticleResearch and practice in thrombosis and haemostasis2024

Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studies.

Johnny Mahlangu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.